Physician

Xiaomei Chen, MD

According to 2025 Medicare claims, Xiaomei Chen, MD (NPI: 1982767828) practices internal medicine in the Trenton-Princeton, NJ market, with the plurality of this provider's patient population coming from Mercer, NJ. This provider's primary affiliated billing organization is PLAINSBORO MEDICAL ASSOCIATES PA (NPI: 1386966760; TIN: 271559180) and primary practice location at 08536-1620. Chen is affiliated with the Optimus Healthcare Partners, LLC (ACO ID: A1059), participating under the MSSP model.

Chen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 344 traditional Medicare patients, billed 7,743 HCPCS/CPT codes, and received $436,540 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 10,914 prescription claims across 537 beneficiaries totaling $1,259,837 in drug costs, led by Prolia (Denosumab). DME data shows 188 claims. Open Payments data shows 13 records totaling $419. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $82,606 to $436,540. Similarly, Part D prescription costs have moved sharply higher in recent years, from $194,487 to $1,259,837. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $2,916 to $21,917.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	134	1,036	$82,606
2016	188	1,671	$126,787
2017	185	2,355	$165,908
2018	262	3,663	$247,800
2019	294	4,547	$294,249
2020	264	4,464	$305,802
2021	271	3,787	$310,115
2022	360	5,109	$407,210
2023	332	5,240	$401,892
2024	344	7,743	$436,540

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	151	2,790	$194,487
2016	193	3,845	$254,305
2017	222	3,847	$287,133
2018	297	5,337	$432,619
2019	364	7,981	$650,510
2020	376	7,994	$796,041
2021	401	7,644	$931,711
2022	504	10,018	$1,352,145
2023	499	11,026	$1,611,241
2024	537	10,914	$1,259,837

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	14	89	$1,671
2016	15	66	$850
2017	30	57	$411
2018	34	95	$1,645
2019	46	96	$891
2020	65	135	$2,376
2021	60	159	$2,439
2022	71	139	$6,617
2023	74	221	$15,104
2024	30	188	$18,550

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	285	1,343	$106
G0446	Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes	268	268	$27
G0442	Annual alcohol misuse screening, 5 to 15 minutes	263	263	$21
G0136	Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes	279	349	$14
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	311	2,126	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prolia	Denosumab	132	23,490	$216,447
Vascepa	Icosapent Ethyl	168	8,635	$92,565
Zenpep	Lipase/Protease/Amylase	38	1,663	$87,088
Vemlidy	Tenofovir Alafenamide	39	1,650	$79,333
Januvia	Sitagliptin Phosphate	72	3,889	$67,877

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	75	$16,667
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	27	$1,068
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	19	43	$463
K0003	Lightweight wheelchair	Y	N/R	16	$322
A4259	Lancets, per box of 100	N	11	27	$30

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$419	Phathom Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Xiaomei Chen, MD?

Tedicare shows public-source Medicare data for Xiaomei Chen, MD (NPI 1982767828), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Xiaomei Chen, MD have ACO affiliation data?

Xiaomei Chen, MD is shown with ACO affiliation data for Optimus Healthcare Partners, LLC (MSSP, ACO ID A1059).

What billing organization is linked to Xiaomei Chen, MD?

Xiaomei Chen, MD is linked to PLAINSBORO MEDICAL ASSOCIATES PA (billing NPI 1386966760) in the available physician profile data.

Does Xiaomei Chen, MD have Open Payments data?

Xiaomei Chen, MD has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.